查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417550

生物模擬市場報告：至2030年的趨勢、預測與競爭分析

Biosimulation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物模擬趨勢和預測

預計到2030年，全球生物模擬市場將達到 68 億美元，2024年至2030年年複合成長率為 13.5%。該市場的主要驅動力是生物相似藥和生技藥品市場的不斷擴大、使用模擬軟體的監管機構數量的增加以及生物技術和製藥領域研發支出的增加。全球生物模擬市場的未來充滿希望，為製藥和生物技術公司、CRO、監管機構和學術研究機構提供了機會。

生物模擬市場洞察

Lucintel 預計，由於政府鼓勵使用先進軟體的措施不斷增加，藥物開發在預測期內仍將是很大的細分市場

由於主要參與者的存在、醫療保健數位化的提高以及慢性健康問題的增加，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模有多大？

A1.到2030年，全球生物模擬市場預計將達到68億美元。

Q2.市場成長預測如何？

A2.2024年至2030年，全球生物模擬市場預計將以13.5%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3.該市場的主要驅動力是生物學名藥和生物製藥市場的擴大、使用模擬軟體的監管機構數量的增加以及生物技術和製藥領域研發支出的增加。

Q4.市場的主要細分市場是什麼？

A4.生物模擬市場的未來性前景廣闊，為製藥和生物技術公司、CRO、監管機構和學術研究機構提供了機會。

Q5.市場上主要企業有哪些？

A5.以下列出了一些主要企業。

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於政府加強鼓勵使用複雜軟體，藥物開發在預測期內仍將佔據較大佔有率。

Q7.未來五年預計哪個地區將成為最大的市場？

A7.由於主要參與者的存在、醫療保健數位化的提高以及慢性健康問題的增加，北美在預測期內將繼續成為最大的地區。

Q8.可以客製化報告嗎？

A8.是的，Lucintel 提供 10%的客製化服務，無需額外付費。

目錄

第1章 執行摘要

第2章 全球生物模擬市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物模擬市場趨勢（2018-2023）與預測（2024-2030）
  • 按交付模式分類的全球生物模擬市場
    • 訂閱模式
    • 所有權模式
  • 依產品分類的全球生物模擬市場
    • 軟體
    • 服務
  • 依應用分類的全球生物模擬市場
    • 藥物開發
    • 藥物發現
    • 其他
  • 依最終用途分類的全球生物模擬市場
    • 製藥和生物技術公司
    • CRO
    • 監管機構
    • 學術研究所

第4章 2018-2030年區域市場趨勢及預測分析

  • 依地區分類的全球生物模擬市場
  • 北美生物模擬市場
  • 歐洲生物模擬市場
  • 亞太生物模擬市場
  • 其他地區生物模擬市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按交付模式分類的全球生物模擬市場成長機會
    • 依產品分類的全球生物模擬市場成長機會
    • 依應用分類的全球生物模擬市場成長機會
    • 依最終用途分類的全球生物模擬市場成長機會
    • 依地區分類的全球生物模擬市場成長機會
  • 全球生物模擬市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物模擬市場的能力
    • 全球生物模擬市場的併購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata
簡介目錄

Biosimulation Trends and Forecast

The future of the global biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software, and growing R&D expenditures in the biotechnology and pharmaceutical sectors.

A more than 150-page report is developed to help in your business decisions.

Biosimulation by Segment

The study includes a forecast for the global biosimulation by delivery model, product, application, end use, and region.

Biosimulation Market by Delivery Model [Shipment Analysis by Value from 2018 to 2030]:

  • Subscription Models
  • Ownership Models

Biosimulation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Software
  • Services

Biosimulation Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Development
  • Drug Discovery
  • Others

Biosimulation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Institutions

Biosimulation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biosimulation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities aCROss the value chain. With these strategies biosimulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biosimulation companies profiled in this report include-

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Biosimulation Market Insights

Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Features of the Global Biosimulation Market

Market Size Estimates: Biosimulation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biosimulation market size by various segments, such as by delivery model, product, application, end use, and region in terms of value ($B).

Regional Analysis: Biosimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different delivery model, product, application, end use, and regions for the biosimulation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biosimulation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biosimulation market size?

Answer: The global biosimulation market is expected to reach an estimated $6.8 billion by 2030.

Q2. What is the growth forecast for biosimulation market?

Answer: The global biosimulation market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biosimulation market?

Answer: The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software and increasing r&d expenditures in the biotechnology and pharmaceutical sectors.

Q4. What are the major segments for biosimulation market?

Answer: The future of the biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research institution markets.

Q5. Who are the key biosimulation market companies?

Answer: Some of the key biosimulation companies are as follows.

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Q6. Which biosimulation market segment will be the largest in future?

Answer: Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

Q7. In biosimulation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biosimulation market by delivery model (subscription models and ownership models), product (software and services), application (drug development, drug discovery, and others), end use (pharmaceutical & biotechnology companies, CROs, regulatory authorities, and academic research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biosimulation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biosimulation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biosimulation Market by Delivery Model
    • 3.3.1: Subscription Models
    • 3.3.2: Ownership Models
  • 3.4: Global Biosimulation Market by Product
    • 3.4.1: Software
    • 3.4.2: Services
  • 3.5: Global Biosimulation Market by Application
    • 3.5.1: Drug Development
    • 3.5.2: Drug Discovery
    • 3.5.3: Others
  • 3.6: Global Biosimulation Market by End Use
    • 3.6.1: Pharmaceutical & Biotechnology Companies
    • 3.6.2: CROs
    • 3.6.3: Regulatory Authorities
    • 3.6.4: Academic Research Institutions

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biosimulation Market by Region
  • 4.2: North American Biosimulation Market
    • 4.2.1: North American Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.2.2: North American Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.3: European Biosimulation Market
    • 4.3.1: European Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.3.2: European Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.4: APAC Biosimulation Market
    • 4.4.1: APAC Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.4.2: APAC Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.5: ROW Biosimulation Market
    • 4.5.1: ROW Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.5.2: ROW Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biosimulation Market by Delivery Model
    • 6.1.2: Growth Opportunities for the Global Biosimulation Market by Product
    • 6.1.3: Growth Opportunities for the Global Biosimulation Market by Application
    • 6.1.4: Growth Opportunities for the Global Biosimulation Market by End Use
    • 6.1.5: Growth Opportunities for the Global Biosimulation Market by Region
  • 6.2: Emerging Trends in the Global Biosimulation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biosimulation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biosimulation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Certara
  • 7.2: Dassault
  • 7.3: Advanced Chemistry Development
  • 7.4: Simulation
  • 7.5: Schrodinger
  • 7.6: Chemical Computing Group
  • 7.7: Physiomics
  • 7.8: Rosa & Co
  • 7.9: BioSimulation Consulting
  • 7.10: Genedata